LENSAR, INC.
StreetZero Signal 53
About LENSAR, INC.
LENSAR, Inc. is a commercial-stage medical device company founded in 2004 and headquartered in Orlando, Florida. It designs, develops, and markets laser systems for cataract treatment and management of corneal astigmatism, with flagship products including the LENSAR Laser System and ALLY Robotic Cataract Laser System. The company operates on a B2B model, serves ophthalmologists and surgical centers globally, and is publicly traded on NASDAQ under the ticker LNSR.
LATEST FUNDINGRule 144
$54K
Announced 2026-11-18
TOTAL RAISED$178M
IN THE NEWS
EMPLOYEES100-200
FOUNDED2004
HQOrlando, FL, United States
Industry
Public Equity (NASDAQ)
Tags
Medical DeviceB2BLaser Technology
Key highlights
- Raised approximately $178 million over 14-15 rounds with historical rounds including $16M Private Equity in 2015.
- Backed by investors including Aisling Capital and Florida Growth Fund.
- Publicly traded on NASDAQ under ticker LNSR.
- Acquired by Alcon in March 2025.
- Develops robotic femtosecond laser systems for cataract surgery with 100-200 employees.
Ask StreetZero about LENSAR, INC.
Put our AI to work on this deal.
Similar companies
Other Public Equity (NASDAQ) deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account